Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.47M | Sell |
51,456
-12,166
| -19% | -$811K | 0.84% | 37 |
|
|
2026
Q1 | $4M | Sell |
63,622
-5,982
| -9% | -$417K | 1.04% | 34 |
|
|
2025
Q4 | $4.62M | Buy |
69,604
+9,656
| +16% | +$624K | 1.13% | 32 |
|
|
2025
Q3 | $4.03M | Buy |
59,948
+10,193
| +20% | +$807K | 1.46% | 25 |
|
|
2025
Q2 | $4.34M | Buy |
49,755
+3,514
| +8% | +$275K | 1.69% | 22 |
|
|
2025
Q1 | $3.16M | Sell |
46,241
-10,493
| -18% | -$856K | 1.35% | 24 |
|
|
2024
Q4 | $4.41M | Sell |
56,734
-37,014
| -39% | -$2.74M | 1.35% | 24 |
|
|
2024
Q3 | $6.29M | Buy |
93,748
+92,719
| +9,011% | +$7.61M | 1.15% | 34 |
|
|
2024
Q2 | $117K | Sell |
1,029
-959
| -48% | -$121K | 0.02% | 224 |
|
|
2024
Q1 | $276K | Buy |
1,988
+275
| +16% | +$34.6K | 0.02% | 194 |
|
|
2023
Q4 | $213K | Sell |
1,713
-781
| -31% | -$79.8K | 0.02% | 215 |
|
|
2023
Q3 | $233K | Buy |
2,494
+335
| +16% | +$37.8K | 0.02% | 198 |
|
|
2023
Q2 | $277K | Hold |
2,159
| – | – | 0.02% | 187 |
|
|
2023
Q1 | $251K | Buy |
2,159
+1,246
| +136% | +$139K | 0.02% | 185 |
|
|
2022
Q4 | $103K | Sell |
913
-826
| -47% | -$90.7K | 0.01% | 294 |
|
|
2022
Q3 | $140K | Sell |
1,739
-3,629
| -68% | -$307K | 0.01% | 241 |
|
|
2022
Q2 | $400K | Buy |
5,368
+696
| +15% | +$63.5K | 0.03% | 182 |
|
|
2022
Q1 | $598K | Sell |
4,672
-2,480
| -35% | -$271K | 0.03% | 167 |
|
|
2021
Q4 | $960K | Sell |
7,152
-1,280
| -15% | -$184K | 0.04% | 120 |
|
|
2021
Q3 | $1.15M | Sell |
8,432
-984
| -10% | -$124K | 0.05% | 116 |
|
|
2021
Q2 | $1M | Sell |
9,416
-11,556
| -55% | -$1.11M | 0.04% | 124 |
|
|
2021
Q1 | $1.88M | Sell |
20,972
-78,920
| -79% | -$7.41M | 0.08% | 107 |
|
|
2020
Q4 | $9.23M | Sell |
99,892
-228,968
| -70% | -$20.4M | 0.41% | 71 |
|
|
2020
Q3 | $33.9M | Sell |
328,860
-47,688
| -13% | -$4.98M | 1.7% | 23 |
|
|
2020
Q2 | $38.2M | Sell |
376,548
-23,128
| -6% | -$2.07M | 2.46% | 8 |
|
|
2020
Q1 | $26.9M | Sell |
399,676
-40,248
| -9% | -$2.5M | 2.13% | 15 |
|
|
2019
Q4 | $24.1M | Sell |
439,924
-137,044
| -24% | -$6.5M | 1.47% | 29 |
|
|
2019
Q3 | $21.5M | Sell |
576,968
-109,912
| -16% | -$4.27M | 1.39% | 28 |
|
|
2019
Q2 | $25.7M | Sell |
686,880
-81,896
| -11% | -$2.57M | 1.43% | 30 |
|
|
2019
Q1 | $22.9M | Buy |
768,776
+212,724
| +38% | +$7.48M | 1.16% | 37 |
|
|
2018
Q4 | $16.7M | Buy |
+556,052
| New | +$17.6M | 0.8% | 45 |
|
|
2018
Q1 | – | Sell |
-6,136
| Closed | -$88K | – | 167 |
|
|
2017
Q4 | $88K | Sell |
6,136
-299,544
| -98% | -$3.89M | ﹤0.01% | 159 |
|
|
2017
Q3 | $3.74M | Buy |
305,680
+193,544
| +173% | +$3.42M | 0.14% | 96 |
|
|
2017
Q2 | $2.05M | Sell |
112,136
-21,508
| -16% | -$397K | 0.08% | 108 |
|
|
2017
Q1 | $2.83M | Buy |
+133,644
| New | +$2.61M | 0.11% | 97 |
|
Other funds holding DXCM
TOBAM's DXCM Position: Q2 2026 in Review
TOBAM reduced its DexCom (DXCM) stake by 19% in Q2 2026, selling an estimated $811K and leaving 51,456 shares worth $3.47M. The position accounts for 0.84% of the portfolio, ranked #37.
TOBAM first reported a position in DXCM in Q1 2017 and has held it in 35 quarters since. The position peaked at $38.2M in Q2 2020. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- TOBAM held 51,456 shares of DexCom worth $3.47M as of Q2 2026.
- TOBAM sold 12,166 DexCom shares in Q2 2026, an estimated $811K.
- DexCom made up 0.84% of TOBAM's portfolio in Q2 2026, its #37 holding.
- TOBAM first reported a position in DexCom in Q1 2017 and has held it in 35 quarters since.
- TOBAM's DexCom position peaked at $38.2M in Q2 2020.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.